Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro

Cancer Gene Therapy

Volumn 6, Issue 6, 1999, Pages 564-571

  Durrbach A ^a   Angevin, E ^b   Poncet, P ^c   Rouleau, M ^a   Chavanel, G ^a   Chapel, A ^d   Thierry, D ^d   Gorter, A ^e   Hirsch, R ^f   Charpentier, B ^a   Senik, A ^a   Hirsch, F ^a  

^a CNRS   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c INSTITUT PASTEUR   (France)

^d INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^e LEIDEN UNIVERSITY   (Netherlands)

^f CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Antifection; Endocytosis; Gene therapy; Renal cell carcinoma; Tumor associated antigen

Indexed keywords

MONOCLONAL ANTIBODY; TUMOR ANTIGEN;

ANIMAL; ARTICLE; ENDOCYTOSIS; GENE TRANSFER; GENETICS; HUMAN; IMMUNOLOGY; KIDNEY CARCINOMA; KIDNEY TUMOR; MOUSE; PLASMID;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; ENDOCYTOSIS; GENE TRANSFER TECHNIQUES; HUMANS; KIDNEY NEOPLASMS; MICE; PLASMIDS;

EID: 0033219613     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700085     Document Type: Article

References (41)

1. Weichselbaum RR, Kufe D. Gene therapy of cancer. Lancet. 1997;349:10-12.
2. Cristiano RJ, Smith LC, Woo SLC. Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes. Proc Natl Acad Sci USA. 1993;90:2122-2126.
3. Schwarzenberger P, Spence SE, Gooya JM, et al. Targeted gene transfer to human hematopoietic progenitor cell lines through the c-kit receptor. Blood. 1996;67:472-478.
4. Zenke M, Steinlein P, Wagner E, et al. Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. Proc Natl Acad Sci USA. 1990;87:3655-3659.
5. Wu GY, Wilson JM, Shalaby F, et al. Receptor-mediated gene delivery in vivo: partial correction of genetic analbuminemia in Nagase rats. J Biol Cliem. 1991;266:14338-14342.
6. Buschle M, Cotten M, Kirlappos H, et al. Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex. Hum Gene Ther. 1995;6:753-761.
7. Hirsch F, Poncet P, Freeman S, et al. Antifection: a new method for targeted gene transfection. Transplant Proc. 1993;25:138-139.
8. Poncet P, Panczak A, Goupy C, et al. Antifection: an antibody-mediated method to introduce genes into lymphoid cells in vitro and in vivo. Gene Ther. 1996;3:731-738.
9. Chapel A, Poncet P, Neildez-Nguyen TMA, et al. Targeted transfection of the IL-3 gene into primary human hematopoietic progenitor cells through the c-kit receptor. Exp Hematol. 1999;27:250-258.
10. Roselli M, Guadagni F, Buonomo O, et al. Tumor markers as targets for selective diagnostic and therapeutic procedures. Anticancer Res. 1996;16:2187-2192.
11. Rosenberg SA, Yang JC, Topalian SL, et al. Treatment of 283 consecutive patients with metastatic melanoma or renal cell cancer using high-dose bolus interleukin 2. JAMA. 1994;271:907-913.
12. Hänninen EL, Kirchner H, Atzpodien J. Interleukin-2 based home therapy of metastatic renal cell carcinoma: risks and benefits in 215 consecutive single institution patients, J Urol. 1995;155:19-25.
13. Negrier S, Escudier B, Lasset CJY, et al. Recombinant human interleukin-2, recombinant human interferon α2a, or both in metastatic renal-cell carcinoma. N Engl J Med. 1998;338:1272-1279.
14. Jaffee EM, Pardoll DM. Gene therapy: its potential applications in the treatment of renal-cell carcinoma. Semin Oncol. 1995;22:81-91.
15. Belldegrun A, Tso CL, Sakata T, et al. Human renal carcinoma line transfected with interleukin-2 and/or interferon α gene(s): implications for live cancer vaccines. J Natl Cancer Inst. 1993;85:207-216.
16. McCune CS, O'Donnell RW, Horan PK, et al. Antitumor immunity induced by hybrid murine tumor cells: requirements for optimal immunization. J Natl Cancer Inst. 1982; 69:647-652.
17. Oosterwijk E, Ruitter DJ, Hoedemaeker PJ, et al. Monoclonal antibody G250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney. Int J Cancer. 1986;38:489-494.
18. Oosterwijk E, Bander NH, Divgi CR, et al. Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250. J Clin Oncol. 1993;11:738-750.
19. Steffens MG, Boerman OC, Oosterwijk-Wakka JC, et al. Targeting of renal cell carcinoma with iodine-131-labeled chimeric monoclonal antibody G250. J Clin Oncol. 1997; 15:1529-1537.
20. Prchla E, Plank C, Wagner E, et al. Virus-mediated release of endosomal content in vitro: different behavior of adenovirus and rhinovirus serotype 2. J Cell Biol. 1995;131: 111-123.
21. Bayer N, Schober D, Prchla E, et al. Effect of bafilomycin Al and nocodazole on endocytic transport in HeLa cells: implications for viral uncoating and infection. J Virol. 1998;72:9645-9655.
22. Cristiano RJ, Curiel DT. Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway. Cancer Gene Ther. 1996;3:49-57.
23. Angevin E, Pavon C, Terrier-Lacombe MJ, et al. Characterization of a renal cell carcinoma xenograft model in SCID mice. Proc Am Assoc Cancer Res. 1997;38:238.
24. Glukhova L, Goguel AF, Schudoba I, et al. Overrepresentation of 7q31 and 17q in renal cell carcinomas. Genes Chromosomes Cancer. 1998;22:171-178.
25. Angevin E, Kremer F, Gaudin C, et al. Analysis of T-cell immune response in renal cell carcinoma: polarization to type 1-like differentiation pattern, clonal T cell expansion, and tumor-specific cytotoxicity. Int J Cancer. 1997;72:434-440.
26. 2-macroglobulin in the same patches on the cell surface of cultured fibroblasts and common internalization. Cell. 1978;14:805-810.
27. Brandzaeg P. Conjugate of immunoglobulin G from different fluorochromes. Scand J Immunol. 1973;2:273-290.
28. Karasuyama H, Melchers F. Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4, or 5, using modified cDNA expression vectors. Eur J Immunol. 1988;18:97-104.
29. Gogusev J, Augusti M, Chrétien Y, et al. Interleukin-6 and TNF-α production in human renal cell carcinoma. Kidney Int. 1992;44:585-592.
30. De Jager R, Abdel-Nabi H, Serafini A, et al. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies. Semin Nucl Med. 1993;23:165-179.
31. Morton DL, Barth A. Vaccine therapy for malignant melanoma. Cancer J Clin. 1996;46:225-244.
32. Young RC. Metastatic renal-cell carcinoma: what causes occasional dramatic regressions? N Engl J Med. 1998;338: 1305-1306.
33. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med. 1996;335:865-875.
34. Angevin E, Valteau-Couanet D, Farace F, et al. A phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 in patients with advanced cancer. J Immunother. 1995;18:188-195.
35. Nayak SK, McCallister T, Han LJ, et al. Transduction of human renal carcinoma cells with human γ-interferon gene via retroviral vector. Cancer Gene Ther. 1996;3:143-150.
36. Hopkins CK, Gibson A, Shipman M, et al. In migrating fibroblasts, recycling receptors are concentrated in narrow tubules in the pericentriolar area and then routed to the plasma membrane of the leading lamella. J Cell Blol. 1994;125:1265-1274.
37. Dürrbach A, Louvard D, Coudrier E. Actin filaments facilitate two steps of endocytosis. J Cell Sci. 1996;109:457-465.
38. Kranenborg M, Boerman OC, de Weijert MCA, et al. The effect of antibody protein dose of anti-renal-cell carcinoma monoclonal antibodies in nude mice with renal-cell carcinoma xenografts. Cancer. 1997;80:2390-2397.
39. Hernandez A, Zöller K, Enczmann J, et al. Differential transfection efficiency rates of the GM-CSF gene into human renal cell carcinoma lines by lipofection. Cancer Gene Ther. 1997;4:59-65.
40. Couffinhal T, Kearney M, Sullivan A, et al. Histochemical staining following LacZ gene transfer underestimates transfection efficiency. Hum Gene Ther. 1997;8:929-934.
41. Fominaya J, Wels W. Target cell-specific DNA transfer mediated by a chimeric multidomain protein. J Biol Chem. 1996;271:10560-10568.